Stephen T. Wills
CFO, COO, Executive VP, Treasurer & SecretaryMr. Stephen T. Wills, also known as Steve, CPA, MST, was Independent Director of Viskase Holdings, Inc. (formerly known as Enzon Pharmaceuticals, Inc.) from January 7, 2025 until March 26, 2026. Mr. Wills served as an Executive Chairman of MediWound Ltd. since May 2019 until August 2022 and also serves as an Independent Director since May 18, 2017. Mr. Wills previously served as the Chairman of the Board of MediWound Ltd since April 2017. He has been the Chief Financial Officer of Palatin Technologies Inc. since November 1997 and has been its Chief Operating Officer and Executive Vice President since June 2011 and Secretary & Treasurer since November 1997. Mr. Wills had been Independent Non-Executive Director of Amryt Pharma plc since September 24, 2019 through April 2023. Mr. Wills was Independent Director of Gamida Cell Ltd. since June 2019 until 2024. He served as an Executive Chairman and Interim Principal Executive Officer at Derma Sciences, Inc from December 21, 2015 to February 24, 2017. He has served in various roles in Palatin since 1997, including as Executive Vice President of Operations from 2005 to June 2011. From July 1997 to August 2000, he served as a Vice President and the Chief Financial Officer of Derma Sciences Inc. Mr. Wills served as the President and Chief Operating Officer of Wills, Owens & Baker, P.C. a public accounting firm, from 1991 to 2000. He has been a Director of U.S. Helicopter Corporation since November 2006. He served on the board of directors of Caliper Corporation since March 2016 and its Chairman from December 2016 to December 2019. Mr. Wills served as a Trustee of The Hun School of Princeton since 2014and its Chairman since June 2018, to his retirement in June 20. He served as a Director at Derma Sciences Inc. from May 2000 to February 24, 2017 and served as its Lead Director since July 2008 until December 21, 2015. From 1991 to 2000, Mr. Wills was the president and Chief Operating Officer of Golomb, Wills & Company, P.C. a public accounting firm. He served as Chief Financial Officer at Cactus Acquisition Corp. 1 Limited from November 2021 until February 23, 2024 and served as its Chief Financial Officer since April 08, 2024. He is a Certified Public Accountant/Member of the American Institute of Certified Public Accountants, New Jersey Society of Certified Public Accountants and Pennsylvania Institute of Certified Public Accountants. Mr. Wills holds a Bachelor of Science degree in Accounting from West Chester University, West Chester, Pennsylvania in 1979 and Master of Science in Taxation from Temple University, Philadelphia, Pennsylvania in 1994.
Positions
- Company NamePalatin Technologies, Inc.Stock CodePTNPositionCFO, COO, Executive VP, Treasurer & SecretaryColleagues
- CSCarl SpanaCo-Founder, President, CEO & Director
- JKJohn K. A. PrendergastIndependent Non-Executive Chairman
- BMBurns McClellanVice President of Investor Relations
- SAStephen A. SlusherChief Legal Officer
- JEJames E. HattersleySenior Vice President of Business Development
- AWAlan W. DuntonIndependent Director
- AMArlene M. MorrisIndependent Director
- RCRaymond C. RosenMember of Female Sexual Dysfunction Expert Panel
- Company NameMediWound Ltd.Stock CodeMDWDPositionIndependent DirectorColleagues
- OGOfer GonenChief Executive Officer
- NSNachum ShamirExecutive Independent Chairman
- HLHani LuxenburgChief Financial Officer
- SHShmulik HessCOO & Chief Commercial Officer
- YMYaron MeyerExecutive VP, General Counsel & Corporate Secretary
- EKEty KlingerChief Medical Officer
- STStephen T. WillsIndependent Director
- DFDavid FoxIndependent Director
- VRVickie R. DriverIndependent Director
- SRShmuel RubinsteinIndependent Director
